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Abstract mRNP3 and mRNP4 (also called FRGY2) are two 
mRNA-binding proteins which are major constituents of the 
maternal RNA storage particles of Xenopus laevis oocytes. The 
phosphorylation of mRNP3-4 has been implicated in the 
regulation of mRNA masking. In this study, we have investigated 
their phosphorylation by casein kinase II and its consequence on 
their affinity for RNA. Comparison of the phosphopeptide map 
of mRNP3-4 phosphorylated in vivo with that obtained after 
phosphorylation in vitro by purified Xenopus laevis casein kinase 
II strongly suggests that casein kinase II is responsible for the in 
vivo phosphorylation of mRNP3-4 in oocytes. The phosphoryla-
tion occurs on a serine residue in a central domain of the proteins. 
The affinity of mRNP3-4 for RNA substrates remained 
unchanged after the treatment with casein kinase II or calf 
intestine phosphatase in vitro. This suggests that phosphorylation 
of these proteins does not regulate their interaction with RNA 
but rather controls their interactions with other proteins. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Oocytes of Xenopus laevis accumulate large amounts of ri-
bosomes, tRNA and mRNA which palliate the absence of 
transcription during the early embryogenesis until the mid-
blastula transition [1]. Stored mRNA which accumulate dur-
ing oogenesis are kept in a stable state and remain untrans-
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lated until they are recruited into polysomes at oocyte matu-
ration and after fertilization [2]. In oocytes, most of the 
maternal mRNAs appear as complexes with a set of specific 
proteins [3,4]. These macromolecular structures, called 
mRNP, are apparently involved in both mRNA protection 
against degradation and masking mRNA from the translation 
apparatus (see e.g. [5,6]). mRNP3-4 are the major 'masking' 
proteins identified, and have been extensively characterized 
[3,7-11]. These proteins are phosphorylated during early oo-
genesis, and mRNA 'masking' in the oocyte depends on their 
phosphorylation state [7,12]. The nucleotide sequence of a 
mRNP4 cDNA is identical to that of FRGY2, a protein ini-
tially characterized as an oocyte transcription factor specific 
for Y-box containing promoters [9,13,14]. mRNP4/FRGY2 
binds RNA with a high affinity and a limited sequence spe-
cificity [15,16]. 
While a number of studies have indicated that phospho-
rylation is involved in the regulation of maternal mRNA stor-
age in Xenopus oocytes, no detailed analysis of this phospho-
rylation has been carried out yet. A casein kinase-II-'like' 
protein which is associated with mRNPs has been proposed 
to be responsible for the phosphorylation of mRNP3^1 [9,17]. 
Previous reports have discussed the possibility that phospho-
rylation could control mRNP assembly (e.g. by modulating 
the affinity of mRNP3^t for RNA) or the fate of assembled 
mRNPs [9,15,18]. To address these issues, we have investi-
gated several aspects of the phosphorylation process of 
mRNP3^4. We present experiments with highly purified 
CKII from X. laevis, which strongly suggest that this kinase 
is responsible for the phosphorylation of mRNP3^1 in oo-
cytes. A biochemical approach allowed us to map the phos-
phorylated domain of mRNP3 and mRNP4. Finally, we have 
also analyzed the effects of phosphorylation on the affinity of 
mRNP3-4 for RNA. 
2. Materials and methods 
2.1. Purification of proteins and peptides 
2.1.1. Proteins and peptides purification. Post-mitochondrial ex-
tract from immature ovaries (later called oocyte extract) was heated 
at 80°C for 10 min [10] and mRNP3/mRNP4 were purified from the 
extract using preparative electrophoresis [10,11]. The peptides were 
purified using the same method except that the gels were stained for 
30 min with freshly prepared 0.1% Coomassie blue R-250 [19] and 
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destained in 10% methanol [20]. The bands were cut out from the gel 
and peptide was electroeluted from the gel as described [21]. Protein 
concentrations were determined as in [11]. 
2.1.2. Refolding of mRNP3 and mRNP4. For in vitro phospho-
rylation and/or RNA-binding analysis of purified mRNP3/mRNP4, 
proteins were refolded as described by Jacquemin-Sablon et al. [16]. 
Previous studies indicated an effective renaturation of mRNP4 under 
these conditions [16]. 
2.1.3. Proteolysis of the proteins. Three kinds of hydrolysis treat-
ments were used to produce mRNP3 or mRNP4 internal peptides. V8 
protease digestion was carried out by mixing 3-5 u,g of either the 
labelled or the unlabelled purified mRNP3/mRNP4 with V8 protease. 
Under our proteolysis conditions, staphylococcal V8 protease specif-
ically cleaves Glu-X bounds except for Glu-Pro; [10,11]. For formic 
acid hydrolysis, proteins were incubated for 2-3 days in formic acid 
80%. In the case of CNBr, proteolysis was performed in 70% formic 
acid and CNBr (molar ratio methionine:CNBr, 1:1000) for 12 h. 
After the reaction, 1 ml of water and 2-3 drops of glycerol were added 
per 100 ul and the sample was dried under vacuum to eliminate the 
formic acid. Dilution with water and drying was repeated once. Sam-
ples were resuspended in 25 u.1 of electrophoresis sample buffer [22]. 
2.2. Identification of the peptides produced by proteolysis 
2.2.1. N-terminal sequencing. Identification of N-terminal se-
quence of peptides was performed according to the described proce-
dure [10,11,20,21]. Note that the N-terminal sequences of several V8 
peptides have already been determined [10]. 
2.2.2. Molecular mass determination by electrospray ionisation mass 
spectrometry. True molecular mass of the peptides was measured as 
described [20]. Peptides were purified by preparative gel electropho-
resis as described above, treated to remove salt and SDS and resolu-
Table 1 
Identification and phosphorylation of mRNP3 and mRNP4 peptides 
Peptide N-term amino acida Proposed aa sequenceb Phosc Mr SDS-PAGE
d Expected Mr Mr ESI-MS 
mRNP4 peptides: V8, formic acid and CNBr proteolysis 
4a 
401 
402 
403 
406 
407 
408 
410 
4.CNBr.a 
4.CNBr.b 
94-
214-
94-
94-
214-
94-
6-
2 1 -
nd 
nd 
94-336 
214-336 
94-213 
94-200 
214-293 
94-155 
6-93 
21-93 
154-336 
1-153 
+++ 
+ / -
+++ 
+++ 
— 
+++ 
+ / -
— 
+ / -
+++ 
44600 
24 500 
23 300 
20600 
17300 
16000 
15 600 
11000 
37000 
25000 
26845 
13351 
13511 
12137 
9156 
6681 
9858 
8213 
20412 
16852 
mRNP3 peptides: V8, formic acid and CNBr proteolysis 
3a 
301 
302 
303-1 
303-2 
304 
305 
3-MC 
306 
3.CNBr.a 
3.CNBr.b 
nd 
94-
99-
105-
214-
214-
11-
214-
2 1 -
nd 
nd 
94-324 
94-213 
99-213 
105-213 
214-324 
or -314 
214-283 
11-93 
214-257 
21-93 
154-324 
1-153 
+++ 
+++ 
+++ 
+++ 
— 
— 
— 
— 
+ / -
+++ 
43000 
23100 
21300 
20000 
20000 
14400 
14200 
12000 
11000 
33000 
25000 
25401 
13289 
12700 
12128 
12130 
11159 
8052 
9409 
4937 
8403 
19107 
16864 
13 500 
12 262 ±6 
11 252 ± 1 
8130±1 
4939±1 
8403 ±1 
"The N-terminal amino acid of the peptides were identified by sequencing, nd, not determined. 
''Proposed peptide localisation. In the case of peptide 303-2, it was not possible to decide between two close C-terminal sites. 
cPhosphorylation state of the peptide after [y-32P]ATP labelling. Occasionally very weak signals were observed for the peptides, we have indicated 
these as: +/—. For peptide 303, a positive signal was observed; it probably originated from peptide 105-213 (303-1) while the peptide starting at 214 
(303-2) would be negative. 
''Apparent molecular mass determination on SDS-PAGE. 
6 Molecular masses of the proposed peptide calculated with the amino acid sequence of FRGY2/mRNP4 [14] and of mRNP3 [13]. Note that the 
peptides starting at aa 1 are necessarily heavier than indicated since the first amino acid of mRNP3 and mRNP4 are blocked. 
fMolecular masses determined by mass spectrometry after electroelution from SDS-PAGE. During this procedure [20] we noted a dephospho-
rylation of the labelled peptides (data not shown). Note that from our results, we can deduce that in our Xenopus oocytes, there is a T (and not an 
A) at the position 254 of mRNP4 [13,14], 
bilized in acetonitrile/H^O/formic acid (50:49:1, v/v/v). Molecular 
mass determination of the peptides was performed on a Trio 2000 
mass spectrometer (VG Biotech, Manchester, UK). 
2.3. Phosphorylations and dephosphorylations 
2.3.1. In vitro and in vivo phosphorylations of mRNP proteins. The 
mRNP proteins were phosphorylated in vitro as described [7,10], In 
vivo phosphorylation of mRNP proteins was performed by incubating 
ovaries in Hg2P04 (Amersham; 10 mCi/ml, carrier free) for 18-20 h at 
20°C in Barth buffer. Phosphorylated mRNP3^1 were purified by 
preparative electrophoresis as described above. 
2.3.2. In vitro phosphorylation of purified and refolded mRNP3l 
mRNP4. Incorporation of phosphate into proteins (0.2-5 ug) using 
CKII was carried out in 25-50 |ll reaction buffer [50 mM Tris-HCl, 
pH 7.5, 0.1 mM EDTA, 5 mM DTT, 300 mM NaCl, 3 mM MgCl2] 
containing 20 uM [y-32P]ATP and 0.1 to 1 ul of Xenopus laevis CKII 
(initial solution of 240 U/u,g and 10-20 u.g/ml), purified to homoge-
neity as previously described [23]. The reaction was carried out at 
20°C and stopped after 40 min by addition of electrophoresis sample 
buffer [22]. 
2.3.3. Dephosphorylation of mRNP3 and mRNP4. Proteins de-
phosphorylation was performed by incubating either an oocyte extract 
or purified mRNP3^1 with calf intestine phosphatase (CIP; Boeh-
ringer). One hundred units of CIP were added per ml of extract and 
the sample was kept for 12 h at 37°C in CIP 10 X buffer (Boehringer). 
Purified protein dephosphorylation occurred in the presence of 400 
units of CIP per ug of protein for 2 h at 37°C. In all cases, in vitro 
32P-phosphorylated mRNP3^1 were used as dephosphorylation con-
trol. 
2.3.4. Phosphoamino acids analysis. Partial acid or basic hydroly-
sis of in vitro labelled mRNP3/mRNP4 were performed according to 
13 358 ±5 
12143 ±4 
9158±1 
6678 ±5 
9856±7 
8212±6 
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[24]. Radiolabelled phosphoamino acids were separated using thin-
layer chromatography and revealed by autoradiography [25]. 
2.4. RNA filter-binding assay 
RNA binding was measured by a nitrocellulose filter assay [26] as 
described in [16]. The RNA substrate contains 456 nucleotides of the 
5' end unr mRNA and a 60 residues poly A tail. Two ng of RNA were 
incubated with 2.5-50 ng of protein in 100 |xl of binding buffer (20 
mM sodium phosphate buffer pH 7.4, 2 mM MgCl2, 1 mM DTT, 20 
|Xg/ml BSA). Controls performed in the absence of mRNP3/mRNP4 
but in the presence of CKII showed no RNA binding to CKII [27] 
under these conditions. 
3. Results 
3.1. mRNP3 and mRNP4 are phosphorylated by CKII on a 
serine residue 
Sequence analysis of mRNP3 and mRNP4 shows 10 and 13 
putative phosphorylation sites for CKII respectively (Fig. 1, 
peptides underlined once). CKII purified from X. laevis oo-
cytes efficiently phosphorylated mRNP3 and mRNP4 in vitro 
(Fig. 2A and B, lanes 4, 5). Analysis of the peptides generated 
by proteolysis with the protease V8 indicated that only some 
of them were phosphorylated (Fig. 2A, lanes 1, 2) suggesting 
that only a few of the potential CKII phosphorylation sites 
were used. As the in vitro phosphorylation sites could differ 
from the in vivo ones, we performed the same peptide analysis 
on in vivo phosphorylated mRNP4. The V8 peptide pattern of 
in vivo labelled mRNP4 was identical to the one previously 
observed (compare Fig. 2B, lane 1 and Fig. 2C, lanes 3, 4). 
Note that when an oocyte extract is incubated with 
[y-32P]ATP, the purified mRNP4 digested by V8 also pre-
sented the same autoradiography pattern (Fig. 2C, lanes 5, 
6). These results indicate that purification and renaturation 
did not modify the phosphorylation sites and strongly suggest 
that CKII is responsible for the in vivo phosphorylation of 
mRNP4 in oocytes. The same conclusion based on compar-
ison of the in vivo and in vitro labelling were obtained for 
mRNP3 (data not shown). 
To identify the amino acid(s) residue(s) which bind phos-
phate, radiolabelled mRNP3 and mRNP4 were submitted to 
Table 2 
Apparent-binding affinity of mRNP3 or mRNP4 for RNA after 
treatment with casein kinase II (CKII) or calf intestine phosphatase 
(CIP) 
Pretreatment 
None 
CKII incubation buffer 
- C K I I 
+CKII 
CIP incubation buffer 
- C I P 
+CIP 
mRNP3 
IQ ± S.D. 
1.8 ±1.0 
2.2 ±0.7 
2.7 ±0.5 
2.6 
3.3 
(nM)» 
mRNP4 
3.5 ±2.0 
nd 
nd 
5.7 ±2.3 
5.8 ±2.6 
"Affinity constant was determined as in [16] (average of three experi-
ments). 
nd, not determined. 
an acidic hydrolysis. Chromatographic analysis indicated that 
only serine residues and neither threonine nor tyrosine resi-
dues were phosphorylated (Fig. 3). 
3.2. Identification of CKII phosphorylation domain in 
mRNP3-4 
In order to identify the phosphorylation domain of mRNP3 
and mRNP4, we used both radiolabelled proteins and ana-
lyzed their V8-peptides (Fig. 2) and two other sets of peptides 
resulting of either formic acid or CNBr treatment (see Table 
1). Formic acid induces specific hydrolysis of Asp-Pro bounds 
and CNBr specifically hydrolyses Met-X bounds (see potential 
sites in Fig. 1). The digestion of mRNP3^l with V8 resulted in 
the production of several peptides, but only a few of them 
were phosphorylated (see results in Table 1 for CNBr and V8 
peptides and [28] for formic acid peptides). The N-terminal 
sequence of some peptides was determined by Edman degra-
dation (Table 1 and [28]). Note that only the peptides result-
ing from an internal cut could be sequenced since the N-ter-
minals of mRNP3 and mRNP4 are blocked, [10,11]. Knowing 
the N-terminal amino acids, the usual procedure to obtain a 
complete identification of the peptides is to measure their 
mRNP3 MSEAEPRETE AVTQPEPGPE IHKPDIVPPR NQINKKLLAT QVQGTVKWFN VRNGYGFINR NDSKEDVFVH 7 0 
mRNP4 .SEAEAQ.P. P.P. . .SEPE .Q..G.AAA. ..A...V TKED.... 
mRNP3 QTAIKKNNPR KFLRSVGDGE TVEFDVVEGE KGAEAANVTG PGGVPVKGSR FAPNSTRFRR QFYRPRADTA 140 
mRNP4 SVGD RR. . . . R TA 
mRNP3 GESGGEGVSP EQMSEGEKGE ETSPQQRPQR RRPPPFFYRR RFRRGPRPNN QQNQGAEVTD QSENKDPAAP 210 
mRNP4 GESGGE MSEGE E ~DPV. . 
t _ 
mRNP3 TSEALASGDG QQRPPPRRFQ QRFRRPFRPR PPPPQTPEGG DGEAKAE-GE PQRQR NRPYVQRRRA 274 
mRNP4 SGDD P A.Q TKAESGE DPRPE R 280 
mRNP3 QQPPTV QGESKAESE- HPASEEGTPS 
mRNP4 .GATQ.AATA ...G...PTQ TPS DSPTD QSSAPDPGIA ..P 
DAPTDDGAPV ETSEAGVE— DTTTAPE 32 4 
336 
Fig. 1. Position of various sites in mRNP3 [13] and mRNP4 [14] amino acids sequences. The phosphorylation minimum consensus sites by 
CKII (S/T-X-X-Acidic) are underlined. Hydrolysable sites by formic acid (D-P) are in italic and underlined twice and the only internal methio-
nine residue in each sequence is indicated by an arrow. Except for the residues implicated in these sites, we have only indicated in mRNP4 the 
amino acids which are different from mRNP3. 
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IN VITRO PHOSPHORYUkTION OF mRNP3 AND mRNP4 BY PURIFIFD CKII 
A Coomassie blue 
1 2 3 4 5 6 kDa 
> 9 6 
mRNP4 _ 
mRNP3 
digested 
by V8(5') 
intact 
B 32 
P Autoradiography 
1 2 3 4 5 6 
digested intact 
by V8(5') 
IN VIVO PHOSPHORYLATION AND IN VITRO PHOSPHORYLATION 
OF mRNP4 
32 
mRNP4 
11 
■S S 
1 2 
_i i _ 
P Autoradiography 
in vivo in vitro 
3 4 5 6 
4 a-
402 
403' 
404-1 
407-
r«rs 
-97 
- 6 6 
- 4 5 
- 3 0 
- 2 0 
- 1 4 
intact digested by V8 5' 20" 5" ZO' 
apparent molecular mass on SDS-PAGE and to deduce their 
C-terminal from the protein sequence and the specificity of the 
sites of proteolysis (V8, Glu-C; formic acid, Asp-Pro; CNBr, 
Met-C). This procedure was very difficult, if not impossible, to 
use in this case because both mRNP3 and mRNP4 present a 
very unusual migration rate on SDS-PAGE [11]. We therefore 
used mass spectrometry to determine the true molecular mass 
of some peptides (Table 1) after SDS-PAGE and electroelu-
tion [20]. A calibration curve was then established relating 
true My. and apparent Mr on SDS-gel (data not shown). In 
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Fig. 2. Phosphorylation of mRNP3 and mRNP4. (A and B) In vitro phosphorylation by purified casein kinase II. Five irg of purified and rena-
tured mRNP3 or mRNP4 were phosphorylated by purified CKII in presence of [y-32P]ATP. Radiolabelled proteins were digested by V8 pro-
tease for 5 min and the peptides produced separated by SDS-PAGE 12.5% and revealed by Coomassie blue staining (A) and autoradiography 
(B). Lanes: 1, mRNP4 V8-digested; 2, mRNP3 V8-digested; 3 and 6, Pharmacia kit of low molecular mass markers; 4, intact mRNP4; 5, in-
tact mRNP3. (C) mRNP4 phosphorylation obtained in vivo by incubation of the ovaries in H|2P04or in vitro by incubation of an oocyte ex-
tract in [y-32P]ATP. Purified radiolabelled mRNP4 was digested by V8 protease, proteolysis products were separated on SDS-PAGE and radio-
labelled peptides revealed by autoradiography. Lanes: 1, intact mRNP4 in vivo labelled; 2, intact mRNP4 in vitro labelled; 3 and 4, in vivo 
labelled mRNP4 digested by V8 for 5 min (lane 3) or 20 min (lane 4); 5 and 6, in vitro labelled mRNP4 digested by V8 for 5 min (5) or 
20 min (6). 
most cases, this procedure allowed us an unambiguous iden-
tification of the peptides (Table 1). For the formic acid and 
CNBr peptides, we could even avoid N-terminal sequencing 
(Table 1). 
Results of peptide localization and phosphorylation are giv-
en in Table 1. It clearly shows that the phosphorylated V8 
peptides derive from digestion of a central protein domain 
from aa 94 to aa 213, see peptides 4a, 402, 403 and 407 for 
mRNP4. No or very little phosphorylation can be observed in 
the N- or C-terminal parts of the protein (see peptides 401 or 
410 for mRNP4). Identical results are obtained with mRNP3. 
Phosphorylation analysis of CNBr and formic acid peptides 
confirm and refine this observation. For example, in the case 
of CNBr proteolysis, only one peptide (from aa 1 to aa 153) is 
phosphorylated (Table 1). In view of these results, we con-
clude that the phospho-acceptor site(s) is(are) present in the 
central part of mRNP3 and mRNP4 between the aa 94 and 
153. 
3.3. Influence of mRNP3-4 phosphorylation state on their 
affinity for RNA 
The phosphorylation state of mRNP3 and mRNP4 might 
directly affect their interaction with RNA. Previously, effect of 
putative casein kinase II on RNA binding has been inferred 
from an indirect test using heparin as a CKII inhibitor [9,15]. 
In this study, we compared the affinity of mRNP3 and 
mRNP4 for RNA following a treatment in vitro with either 
purified CKII or calf intestinal phosphatase (Table 2). We 
previously used a filter binding assay to investigate the affinity 
of mRNP3^1 for RNA [16]. We have shown that mRNP3^1 
purified from oocytes has a high affinity (K& = 3 nM) and only 
limited specificity for long substrates of complex sequence 
such as mRNAs. Using the same assay and a probe derived 
from the unr mRNA, we show that the affinity constants are 
identical after CIP or CKII treatment of mRNP3^1 (Table 2). 
Incubation of mRNP3^1 in the appropriate buffers had no 
significant effect on RNA binding (Table 2). 
Therefore, phosphorylation by CKII or dephosphorylation 
by CIP did not significantly alter the affinity of mRNP3^1 for 
RNA. 
4. Discussion 
<S 
4 T 
Fig. 3. Phosphoamino acid analysis of mRNP3 and mRNP4. 
mRNP3 and mRNP4 proteins were phosphorylated in vitro with 
[y-32P]ATP. 32P-labelled proteins were separated on SDS-PAGE, 
electro-transferred to Immobilon membranes and subjected to parti-
al acid hydrolysis as described [24]. The products were mixed with 
unlabelled phosphoamino acid standards and resolved on thin-layer 
cellulose plate by electrophoresis at pH 3.5. Unlabelled phospho-
amino acids were visualized by ninhydrin staining and 32P-labelled 
phosphoamino acids were revealed by autoradiography. The posi-
tions of phosphoserine (S), phosphothreonine (T) and phosphotyro-
sine are indicated by dark arrows. White arrow indicates free 32P in 
the migration front. Lanes: 1, mRNP3; 2, mRNP3+mRNP4; 3, 
mRNP4. 
In this study we could show that the phosphopeptide map 
of mRNP3^l phosphorylated in vitro by purified Xenopus 
CKII is indistinguishable from that of mRNP3-4 phospho-
rylated in vivo. This result strongly argues in favour of the 
CKII involvement in the phosphorylation of mRNP3^l in 
vivo. It validates the suggestion from previous studies that a 
CKII-'like' protein could be implicated in the phosphoryl-
ation of mRNP3 and mRNP4 in Xenopus oocytes [8,9,17]. 
The phosphorylated peptides were derived from a central do-
main (aa 94-153) which contains 3 conserved serine residues 
(119, 143 and 149), a fourth one (125) is present only in 
mRNP3 (Fig. 1). As during Edman degradation of the rele-
vant peptides (see [10] for the sequences of peptides 405 and 
303) normal amounts of serine 119 were detected, we can 
exclude that phosphorylation occurs on that residue (see for 
example [29]). Finally, while serine 149 is followed by a pro-
line which is detrimental for phosphorylation by CKII [30,31], 
serine 143 is present in the (S/T-X-X-Acidic) consensus se-
quence (Fig. 1) and is therefore, the most likely substrate of 
CKII. 
mRNP3 and mRNP4 are the principal constituents of the 
mRNA storage particles and have been implicated in mRNA 
masking from translation [7,12,32-34]. An appropriate phos-
phorylation of mRNP3^1 has been shown to be required for 
mRNA masking [12,33] but its precise role is still poorly 
understood. CKII could regulate mRNA masking in oocytes 
by acting either on the interaction of mRNP3^1 with RNA or 
500 S. Deschamps et al.lFEBS Letters 412 (1997) 495-500 
by controlling the fate of assembled m R N P s . Previous reports 
have described conflicting results on the role of phosphoryl-
ation on RNA-binding affinity. Kick et al. [12] observed a 
lower affinity of m R N P 4 for p-globin and poly A R N A 
following dephosphorylation, while Tafuri and Wolffe [35] 
found no difference in the RNA-binding properties of native 
m R N P 4 from Xenopus oocyte or bacterially expressed 
m R N P 4 which is not phosphorylated, suggesting that proper 
phosphorylation is not essential. In the present study we have 
used a quantitative assay to show that the affinity of native 
m R N P 3 ^ 1 remains unchanged whether phosphorylated by 
CKI I purified from Xenopus oocyte or dephosphorylated by 
calf intestine phosphatase. Our results conclusively indicate 
that CKI I does not directly regulate the interaction of 
m R N P 3 and m R N P 4 with R N A . Therefore, regulation of 
m R N A masking by CKI I has to occur at another level, one 
possibility being that the phosphorylation of m R N P 3 ^ 1 con-
trols their interaction with other proteins, either other constit-
uents of m R N P , or, possibly, factors directly involved in 
translation. 
The simplicity of the phosphorylation pat tern of m R N P 3 - 4 
in oocytes should facilitate the investigation of its functional 
role. F o r instance, mutagenesis of the phosphorylation site 
will provide a tool to determine its role in m R N A masking. 
Moreover, the analysis of m R N P 3 ^ 1 phosphorylation during 
early development and the search for the corresponding ki-
nases should now be feasible. 
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